+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5521476
  • Report
  • October 2021
  • Region: Global
  • 296 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Ahlstrom-Munksjo
  • Becton
  • Caldera Medical
  • Coloplast A/S
  • Cook Group Inc.
  • Freudenberg & Co. KG
The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030.



The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC). In incontinence, there is involuntary or accidental release of the contents from the urinary bladder, known as urinary incontinence or over rectal muscle (bowel or flatulence) known as rectal incontinence. Incontinence is a widespread condition that ranges in severity from just a small leak to complete loss of bladder or bowel control. Disposable incontinence products are primarily used by the people suffering from urinary incontinence. These are mostly used by the elderly population, who are unable to control the urinary influx. The disposable incontinence products are preferably made up of medical grade nonwoven fabrics. Medical nonwovens are a distinctive class of textile materials designed from fibers that are bonded together to form a lucid structure. Medical nonwovens are either made up of natural fiber-like cotton, linen, or of synthetic materials such as polypropylene, polyester, polytetrafluoroethylene (PTFE), and others. Medical nonwoven disposable incontinence products are commonly used in surgical processes, serving as a barrier to microorganisms, and prevent infections.

Development of innovative urinary incontinence devices and rise in demand for minimally invasive surgeries along with increase in aging population that is highly susceptible to urological conditions drive the growth of the urinary incontinence devices market. In addition, the increase in the urinary incontinent patients transitioning from conventional solutions is set to increase in near future. Further, high risk of associative urological conditions among people supplements the growth of the market. However, lack of awareness regarding novel developments in the urinary incontinence devices and post-operative complications associated with the devices hamper the market growth. Moreover, the growth in healthcare expenditures in the developing economies is anticipated to create numerous opportunities for key vendors in this market.

The urinary incontinence market is segmented on the basis of product, incontinence type, end user, and region. By product, the market is divided into devices and disposables. The devices segment is further bifurcated into urinary catheters, vaginal slings, Electrical stimulation devices, artificial urinary sphincters, other devices and category. Urinary catheters are sub segmented into Foley catheters and other urinary catheters. Vaginal slings segment is sub segmented into conventional vaginal slings and advanced vaginal slings. On the basis of category, it is classified into external urinary incontinence devices and internal urinary incontinence devices. The disposables segment is further divided into disposable underwear, disposable shields, disposable diapers, disposable underpads, and others. By incontinence type, the market is categorized into stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Further, by end user, it is classified into hospitals and clinics, homecare, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson and Johnson, Laborie Medical, Medtronic Plc., Teleflex Incorporated, Ahlstrom-Munksjo, Asahi Kasei Corporation, Berry Global Inc., Cardinal Health, Inc., Domtar Corporation, First Quality Enterprises, Inc., Freudenberg and Co. KG, Georgia-Pacific LLC, Kimberly-Clark Corporation, and Unicharm Corporation.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global urinary incontinence market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of urinary incontinence device used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Product

  • Devices
  • Urinary Catheters
  • Foley Catheters
  • Other Urinary Catheters
  • Vaginal Slings
  • Conventional Vaginal Slings
  • Advanced Vaginal Slings
  • Electrical Stimulation Devices
  • Artificial Urinary Sphincters
  • Other Devices
  • Category
  • External Urinary Incontinence Devices
  • Internal Urinary Incontinence Devices
  • Disposables
  • Disposable Underwear
  • Disposable Shields
  • Disposable Diapers
  • Disposable Underpads
  • Others

By Incontinence Type

  • Stress Urinary Incontinence
  • Urge Urinary Incontinence
  • Overflow Urinary Incontinence
  • Functional Urinary Incontinence

By End User

  • Hospitals and Clinics
  • Home Care
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

List of key players profiled in the report:
  • Becton, Dickinson and Company (C.R. Bard Inc.)
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast A/S
  • ConvaTec Group PLC
  • Cook Group Inc.
  • Johnson and Johnson
  • Laborie Medical
  • Medtronic plc
  • Teleflex Incorporated
  • Ahlstrom-Munksjo
  • Asahi Kasei Corporation
  • Berry Global Inc.
  • Cardinal Health, Inc.
  • Domtar Corporation
  • First Quality Enterprises, Inc.
  • Freudenberg & Co. KG
  • Georgia-Pacific LLC
  • Kimberly-Clark Corporation
  • Unicharm Corporation
Frequently Asked Questions about the Global Urinary Incontinence Market

What is the estimated value of the Global Urinary Incontinence Market?

The Global Urinary Incontinence Market was estimated to be valued at $10124.3 million in 2020.

What is the growth rate of the Global Urinary Incontinence Market?

The growth rate of the Global Urinary Incontinence Market is 6.7%, with an estimated value of $19341.2 million by 2030.

What is the forecasted size of the Global Urinary Incontinence Market?

The Global Urinary Incontinence Market is estimated to be worth $19341.2 million by 2030.

Who are the key companies in the Global Urinary Incontinence Market?

Key companies in the Global Urinary Incontinence Market include Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson and Johnson and Medtronic plc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ahlstrom-Munksjo
  • Becton
  • Caldera Medical
  • Coloplast A/S
  • Cook Group Inc.
  • Freudenberg & Co. KG

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s Five Forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Development of innovative urinary incontinence devices & rising
demand for minimally invasive procedures
3.5.1.2. Increase in aging population coupled with high risk of urological
disorders
3.5.1.3. Rise in shift from conventional solutions to novel urinary incontinent products
3.5.1.4. Growth in elderly population
3.5.1.5. Efficiency in the prevention of hospital-acquired infections (HAIs)
3.5.2. Restraints
3.5.2.1. Lack of awareness regarding novel developments in the urinary incontinence devices coupled with underreported cases of urinary incontinence
3.5.2.2. Post-operative complications associated with the devices
3.5.2.3. Rise in concerns toward disposal products
3.5.3. Opportunities
3.5.3.1. Growth in healthcare expenditures in the developing economies
3.5.3.2. Rise in technology integration
3.5.4. Impact analysis
3.6. COVID-19 Impact analysis on urinary incontinence market
CHAPTER 4: URINARY INCONTINENCE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market size and forecast, by devices
4.2.4. Market share analysis, by country
4.2.5. Urinary catheters
4.2.5.1. Key trends and opportunities
4.2.5.2. Market size and forecast
4.2.5.3. Foley catheters
4.2.5.4. Other urinary catheters
4.2.6. Vaginal slings
4.2.6.1. Key trends and opportunities
4.2.6.2. Market size and forecast
4.2.6.3. Conventional vaginal slings
4.2.6.4. Advanced vaginal slings
4.2.7. Electrical stimulation devices
4.2.7.1. Key trends and opportunities
4.2.8. Artificial urinary sphincters
4.2.8.1. Key trends and opportunities
4.2.9. Other devices
4.2.9.1. Key trends and opportunities
4.2.10. Urinary incontinence devices market size and forecast, by category
4.2.10.1. Market size and forecast
4.2.10.2. External urinary incontinence devices
4.2.10.3. Internal urinary incontinence devices
4.3. Disposables
4.3.1. Market size and forecast
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis, by country
4.3.4. Disposable underwear
4.3.4.1. Key market trends and opportunities
4.3.5. Disposable shields
4.3.5.1. Key market trends and growth opportunities
4.3.6. Disposable diapers
4.3.6.1. Key market trends and opportunities
4.3.7. Disposable underpads
4.3.7.1. Key market trends and opportunities
4.3.8. Others
4.3.8.1. Key market trends and opportunities
CHAPTER 5: URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Stress urinary incontinence
5.2.1. Market size and forecast by region.
5.2.2. Market analysis, by country
5.3. Urge urinary incontinence
5.3.1. Market size and forecast by region.
5.3.2. Market analysis, by country
5.4. Overflow urinary incontinence
5.4.1. Market size and forecast by region
5.4.2. Market analysis, by country
5.5. Functional urinary incontinence
5.5.1. Market size and forecast by region
5.5.2. Market analysis, by country
CHAPTER 6: URINARY INCONTINENCE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals and Clinics
6.2.1. Market size and forecast by region.
6.2.2. Market analysis, by country
6.3. Home Care
6.3.1. Market size and forecast by region
6.3.2. Market share analysis, by country
6.4. Others
6.4.1. Market size and forecast by region.
6.4.2. Market share analysis, by country
CHAPTER 7: URINARY INCONTINENCE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by incontinence type
7.2.4. Market size and forecast, by end user
7.2.5. Market size & forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by product
7.2.5.1.2. Market size and forecast, by incontinence type
7.2.5.1.3. Market size and forecast by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by product
7.2.5.2.2. Market size and forecast by incontinence type
7.2.5.2.3. Market size and forecast, by end user
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast by product
7.2.5.3.2. Market size and forecast, by incontinence type
7.2.5.3.3. Market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by incontinence type
7.3.4. Market size and forecast, by end user
7.3.5. Europe market size & forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by product
7.3.5.1.2. Market size and forecast, by incontinence type
7.3.5.1.3. Market size and forecast by end user
7.3.5.2. France
7.3.5.2.1. Market size and forecast by product
7.3.5.2.2. Market size and forecast by incontinence type
7.3.5.2.3. Market size and forecast by end user
7.3.5.3. UK
7.3.5.3.1. Market size and forecast by product
7.3.5.3.2. Market size and forecast by incontinence type
7.3.5.3.3. Market size and forecast by end user
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast by product
7.3.5.4.2. Market size and forecast by incontinence type
7.3.5.4.3. Market size and forecast by end user
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast by product
7.3.5.5.2. Market size and forecast by incontinence type
7.3.5.5.3. Market size and forecast by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast by product
7.3.5.6.2. Market size and forecast by incontinence type
7.3.5.6.3. Market size and forecast by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by incontinence type
7.4.4. Market size and forecast, by end user
7.4.5. Asia-Pacific market size & forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by product
7.4.5.1.2. Market size and forecast, by incontinence type
7.4.5.1.3. Market size and forecast by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by product
7.4.5.2.2. Market size and forecast, by incontinence type
7.4.5.2.3. Market size and forecast by end user
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by product
7.4.5.3.2. Market size and forecast, by incontinence type
7.4.5.3.3. Market size and forecast by end user
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by product
7.4.5.4.2. Market size and forecast, by incontinence type
7.4.5.4.3. Market size and forecast by end user
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by product
7.4.5.5.2. Market size and forecast, by incontinence type
7.4.5.5.3. Market size and forecast by end user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by product
7.4.5.6.2. Market size and forecast, by incontinence type
7.4.5.6.3. Market size and forecast by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by incontinence type
7.5.4. Market size and forecast, by end user
7.5.5. LAMEA market size & forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by product
7.5.5.1.2. Market size and forecast, by incontinence type
7.5.5.1.3. Market size and forecast by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by product
7.5.5.2.2. Market size and forecast, by incontinence type
7.5.5.2.3. Market size and forecast by end user
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by product
7.5.5.3.2. Market size and forecast, by incontinence type
7.5.5.3.3. Market size and forecast by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by product
7.5.5.4.2. Market size and forecast, by incontinence type
7.5.5.4.3. Market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. BECTON, DICKINSON AND COMPANY (C.R. BARD INC.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. BOSTON SCIENTIFIC CORPORATION
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. CALDERA MEDICAL
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. COLOPLAST A/S
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. CONVATEC GROUP PLC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. COOK GROUP INC. (COOK MEDICAL INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. JOHNSON & JOHNSON (ETHICON INC.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. LABORIE MEDICAL (COGENTIX MEDICAL INC.)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. MEDTRONIC PLC
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. TELEFLEX INCORPORATED
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.11. AHLSTROM-MUNKSJO
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.11.6. Key strategic moves and developments
8.12. ASAHI KASEI CORPORATION
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance
8.12.6. Key strategic moves and developments
8.13. BERRY GLOBAL INC.
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance
8.14. CARDINAL HEALTH, INC.
8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Operating business segments
8.14.4. Product portfolio
8.14.5. Business performance
8.15. DOMTAR CORPORATION
8.15.1. Company overview
8.15.2. Operating business segments
8.15.3. Product portfolio
8.15.4. Business performance
8.15.5. Key strategic moves and developments
8.16. FIRST QUALITY ENTERPRISES, INC.
8.16.1. Company overview
8.16.2. Company snapshot
8.16.3. Operating business segments
8.16.4. Product portfolio
8.16.5. Key strategic moves and developments
8.17. FREUDENBERG & CO. KG
8.17.1. Company overview
8.17.2. Company snapshot
8.17.3. Operating business segments
8.17.4. Product portfolio
8.18. GEORGIA-PACIFIC LLC
8.18.1. Company overview
8.18.2. Company snapshot
8.18.3. Operating business segments
8.18.4. Product portfolio
8.19. KIMBERLY-CLARK CORPORATION
8.19.1. Company overview
8.19.2. Company snapshot
8.19.3. Operating business segment
8.19.4. Product portfolio
8.19.5. Business performance
8.20. UNICHARM CORPORATION
8.20.1. Company Overview
8.20.2. Company snapshot
8.20.3. Operating business segments
8.20.4. Product portfolio
8.20.5. Business performance
List of Tables
TABLE 01. URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02. URINARY INCONTINENCE MARKET FOR DEVICES, BY REGION, 2020-2030, ($MILLION)
TABLE 03. GLOBAL URINARY INCONTINENCE MARKET FOR DEVICES, 2020-2030, ($MILLION)
TABLE 04. GLOBAL URINARY INCONTINENCE MARKET FOR URINARY CATHETERS, 2020-2030 ($MILLION)
TABLE 05. EXAMPLE OF ANTI-MICROBIAL FOLEY CATHETER URINARY INCONTINENCE
TABLE 06. GLOBAL URINARY INCONTINENCE MARKET FOR VAGINAL SLINGS, 2020-2030, ($MILLION)
TABLE 07. GLOBAL URINARY INCONTINENCE MARKET, BY CATEGORY, 2020-2030, ($MILLION)
TABLE 08. URINARY INCONTINENCE MARKET FOR DISPOSABLE PRODUCTS, 2020-2030 ($MILLION)
TABLE 09. URINARY INCONTINENCE MARKET FOR DISPOSABLE PRODUCTS, BY REGION, 2020-2030, ($MILLION)
TABLE 10. GLOBAL URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 11. DEVICES USED IN THE TREATMENT OF STRESS URINARY INCONTINENCE
TABLE 12. STRESS URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($ MILLION)
TABLE 13. EXAMPLE OF ELECTROSTIMULATION DEVICE USED IN THE TREATMENT OF URGE URINARY
INCONTINENCE107
TABLE 14. URGE URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($ MILLION)
TABLE 15. DEVICES USED IN THE TREATMENT OF OVERFLOW URINARY INCONTINENCE
TABLE 16. OVERFLOW URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17. FUNCTIONAL URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18. GLOBAL URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($ MILLION)
TABLE 19. URINARY INCONTINENCE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($ MILLION)
TABLE 20. URINARY INCONTINENCE MARKET FOR HOME CARE, BY REGION, 2020-2030 ($ MILLION)
TABLE 21. URINARY INCONTINENCE MARKET FOR OTHERS, BY REGION, 2020-2030 ($ MILLION)
TABLE 22. GLOBAL URINARY INCONTINENCE MARKET, BY REGION, 2020-2030($MILLION)
TABLE 23. NORTH AMERICA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24. NORTH AMERICA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 25. NORTH AMERICA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26. NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030($MILLION)
TABLE 27. U.S. URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28. U.S. URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 29. U.S. URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30. CANADA URINARY INCONTINENCE MARKET, BY PRODUCT, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 31. CANADA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 32. CANADA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33. MEXICO URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 34. MEXICO URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 35. MEXICO URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 36. EUROPE URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37. EUROPE URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 38. EUROPE URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39. EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030 ($MILLION)
TABLE 40. GERMANY URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 41. GERMANY URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 42. GERMANY URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43. FRANCE URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 44. FRANCE URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 45. FRANCE URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46. UK URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 47. UK URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 48. UK URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 49. ITALY URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 50. ITALY URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 51. ITALY URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52. SPAIN URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 53. SPAIN URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 54. SPAIN URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55. REST OF EUROPE URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 56. REST OF EUROPE URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 57. REST OF EUROPE URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 58. ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 59. ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 60. ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61. ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030($MILLION)
TABLE 62. JAPAN URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 63. JAPAN URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 64. JAPAN URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65. CHINA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 66. CHINA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 67. CHINA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68. AUSTRALIA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 69. AUSTRALIA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 70. AUSTRALIA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71. INDIA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 72. INDIA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 73. INDIA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74. SOUTH KOREA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 75. SOUTH KOREA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 76. SOUTH KOREA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 77. REST OF ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 78. REST OF ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE,
2020-2030 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 80. LAMEA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 81. LAMEA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 82. LAMEA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 83. LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030($MILLION)
TABLE 84. BRAZIL URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 85. BRAZIL URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 86. BRAZIL URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 87. SAUDI ARABIA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 88. SAUDI ARABIA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 89. SAUDI ARABIA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90. SOUTH AFRICA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 91. SOUTH AFRICA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 92. SOUTH AFRICA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 93. REST OF LAMEA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 94. REST OF LAMEA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 95. REST OF LAMEA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 96. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 97. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 98. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 99. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 100. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 101. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 102. CALDERA: COMPANY SNAPSHOT
TABLE 103. CALDERA: OPERATING SEGMENTS
TABLE 104. CALDERA: PRODUCT PORTFOLIO
TABLE 105. COLOPLAST: COMPANY SNAPSHOT
TABLE 106. COLOPLAST: OPERATING SEGMENTS
TABLE 107. COLOPLAST: PRODUCT PORTFOLIO
TABLE 108. CONVATEC: COMPANY SNAPSHOT
TABLE 109. CONVATEC: OPERATING SEGMENTS
TABLE 110. CONVATEC: PRODUCT PORTFOLIO
TABLE 111. COOK GROUP: COMPANY SNAPSHOT
TABLE 112. COOK GROUP: OPERATING SEGMENTS
TABLE 113. COOK GROUP: PRODUCT PORTFOLIO
TABLE 114. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 115. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 116. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 117. LABORIE MEDICAL: COMPANY SNAPSHOT
TABLE 118. LABORIE: OPERATING SEGMENTS
TABLE 119. LABORIE: PRODUCT PORTFOLIO
TABLE 120. MEDTRONIC: COMPANY SNAPSHOT
TABLE 121. MEDTRONIC: OPERATING SEGMENTS
TABLE 122. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 123. TELEFLEX: COMPANY SNAPSHOT
TABLE 124. TELEFLEX: OERATING SEGMENT
TABLE 125. TELEFLEX: PRODUCT PORTFOLIO
TABLE 126. AHLSTROM: COMPANY SNAPSHOT
TABLE 127. AHLSTROM: OPERATING BUSINESS SEGMENTS
TABLE 128. AHLSTROM: PRODUCT PORTFOLIO
TABLE 129. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 130. ASAHI KASEI: PRODUCT BUSINESS SEGMENT
TABLE 131. ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 132. BERRY: COMPANY SNAPSHOT
TABLE 133. BERRY: OPERATING BUSINESS SEGMENTS
TABLE 134. BERRY: PRODUCT PORTFOLIO
TABLE 135. CARDINAL: COMPANY SNAPSHOT
TABLE 136. CARDINAL: OPERATING SEGMENTS
TABLE 137. CARDINAL: PRODUCT PORTFOLIO
TABLE 138. DOMTAR.: COMPANY SNAPSHOT
TABLE 139. DOMTAR.: OPERATING BUSINESS SEGMENTS
TABLE 140. DOMTAR.: PRODUCT PORTFOLIO
TABLE 141. FIRST QUALITY: COMPANY SNAPSHOT
TABLE 142. FIRST QUALITY: OPERATING BUSINESS SEGMENTS
TABLE 143. FIRST QUALITY: PRODUCT PORTFOLIO
TABLE 144. FREUDENBERG: COMPANY SNAPSHOT
TABLE 145. FREUDENBERG NONWOVENS: OPERATING SEGMENT
TABLE 146. FREUDENBERG: PRODUCT PORTFOLIO
TABLE 147. GEORGIA: COMPANY SNAPSHOT
TABLE 148. GEORGIA: OPERATING SEGMENTS
TABLE 149. GEORGIA: PRODUCT PORTFOLIO
TABLE 150. KIMBERLY: COMPANY SNAPSHOT
TABLE 151. KIMBERLY: OPERATING SEGMENT
TABLE 152. KIMBERLY: PRODUCT PORTFOLIO
TABLE 153. UNICHARM: COMPANY SNAPSHOT
TABLE 154. UNICHARM: OPERATING SEGMENTS
TABLE 155. UNICHARM: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. SEGMENTATION OF URINARY INCONTINENCE MARKET
FIGURE 02. TOP INVESTMENT POCKETS IN URINARY INCONTINENCE MARKET, 2020
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2019-2021*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTION
FIGURE 09. MODERATE THREAT OF NEW ENTRANT
FIGURE 10. MODERATE COMPETITIVE RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, URINARY INCONTINENCE DEVICES MARKET, 2020
FIGURE 12. TOP PLAYER POSITIONING, DISPOSABLE INCONTINENCE PRODUCTS MARKET, 2020
FIGURE 13. IMPACT ANALYSIS
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF URINARY INCONTINENCE MARKET FOR DEVICES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF URINARY INCONTINENCE MARKET FOR DISPOSABLE PRODUCTS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. MARKET SIZE AND FORECAST OF STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. MARKET SIZE AND FORECAST OF URGE URINARY INCONTINENCE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. MARKET SIZE AND FORECAST OF OVERFLOW URINARY INCONTINENCE MARKET, BY COUNTRY, 2020 & 2030(%)
FIGURE 19. MARKET SIZE AND FORECAST OF FUNCTIONAL URINARY INCONTINENCE MARKET, BY COUNTRY, 2020 & 2030(%)
FIGURE 20. MARKET SIZE AND FORECAST OF URINARY INCONTINENCE FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030(%)
FIGURE 21. MARKET SIZE AND FORECAST OF URINARY INCONTINENCE MARKET FOR HOME CARE, BY COUNTRY, 2020 & 2030(%)
FIGURE 22. MARKET SIZE AND FORECAST OF URINARY INCONTINENCE MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030(%)
FIGURE 23. BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26. BOSTON SCIENTIFIC: NET SALES, 2018-2020 ($MILLION)
FIGURE 27. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28. BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29. COLOPLAST: NET SALES, 2018-2020 ($MILLION)
FIGURE 30. COLOPLAST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. COLOPLAST: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32. CONVATEC: NET SALES, 2018-2020 ($MILLION)
FIGURE 33. CONVATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. CONVATEC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35. JOHNSON & JOHNSON: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. MEDTRONIC: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. TELEFLEX: NET SALES, 2018-2020 ($MILLION)
FIGURE 42. TELEFLEX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43. TELEFLEX: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 44. AHLSTROM: NET SALES, 2018-2020 ($MILLION)
FIGURE 45. AHLSTROM: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 46. AHLSTROM: REVENUE SHARE BY REGION, 2020(%)
FIGURE 47. ASAHI KASEI: NET SALES, 2018-2020 ($MILLION)
FIGURE 48. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 49. BERRY: NET SALES, 2018-2020 ($MILLION)
FIGURE 50. BERRY: REVENUE SHARE BY REGION SEGMENT, 2020(%)
FIGURE 51. BERRY: REVENUE SHARE BY REGION, 2020(%)
FIGURE 52. CARDINAL: NET SALES, 2018-2020 ($MILLION)
FIGURE 53. CARDINAL: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 54. CARDINAL: REVENUE SHARE BY REGION, 2020(%)
FIGURE 55. DOMTAR: NET SALES, 2018-2020 ($MILLION)
FIGURE 56. DOMTAR: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57. FREUDENBERG: NET SALES, 2018-2020 ($MILLION)
FIGURE 58. FREUDENBERG: REVENUE BY SEGMENT, 2020 (%)
FIGURE 59. FREUDENBERG: REVENUE BY REGION, 2018(%)
FIGURE 60. KIMBERLY: NET SALES, 2018-2020 ($MILLION)
FIGURE 61. KIMBERLY: REVENUE BY SEGMENT, 2020 (%)
FIGURE 62. KIMBERLY: REVENUE BY REGION, 2020 (%)
FIGURE 63. UNICHARM: NET SALES, 2018-2020 ($MILLION)
FIGURE 64. UNICHARM: REVENUE SHARE BY SEGMENT, 2020 (%)
Note: Product cover images may vary from those shown
  • Becton
  • Dickinson and Company (C.R. Bard Inc.)
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast A/S
  • ConvaTec Group plc
  • Cook Group Inc.
  • Johnson and Johnson
  • Laborie Medical
  • Medtronic plc
  • Teleflex Incorporated
  • Ahlstrom-Munksjo
  • Asahi Kasei Corporation
  • Berry Global Inc.
  • Cardinal Health Inc.
  • Domtar Corporation
  • First Quality Enterprises Inc.
  • Freudenberg & Co. KG
  • Georgia-Pacific LLC
  • Kimberly-Clark Corporation
  • Unicharm Corporation
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...